Drug delivery market to reach $1.6bn

New drug delivery systems to enter healthcare over the next decade.

New vaccine delivery technologies for better immune response

Clinical trials show delivery of vaccines via new techniques induce greater immune responses than traditional methods.

Samsung Biologics and AstraZeneca expand partnership

Samsung Biologics expanded its biopharmaceutical manufacturing collaboration with AstraZeneca based on a long-term strategic deal.

View the latest program

Past attendees:

BDD Pharma
Thorne HealthTech
Bayer
Human Metabolome Technologies
Biomillenia
Symbiome
Evonik Corporation
Concerto Biosciences
Matrivax Corporation
MBF Therapeutics
iBET
Harvard University

Expert Speakers to Date

Tsute Chen
The Forsyth Institute
Kamlesh Oza
Evonik Corporation
Cheri Ackerman
Concerto Biosciences
Nini Fan
MaMome Inc.
Fiona MacDougall
BDD Pharma Ltd
Antonio Roldao
iBET
Gregory Tobin
Biological Mimetics
Tom Tillett
MBF Therapeutics
Kevin Killeen
Matrivax Corporation
Anna Särnefält
CEPI

Who should attend

Drug Development
Drug Delivery Systems
Drug Discovery
Biotherapeutics and Biologics
Biotechnology Research
Nanotechnologies
Nano and Micro Robotics
Modalities Research
Molecular Medicine
Drug Manufacturing
Drug Formulation
Clinical Trials
Clinical Diagnostics
Companion Diagnostics
Clinical Microbiology
System Biology and Research
Precision Medicine
Laboratory Equipment
Business Development
Clinical Trials and Approvals
Manufacturing Research & Innovation
Research and Development
Strategy, Projects, & Public Affairs
Sales and Marketing Initiatives
Legal and Regulatory
Equipment Certification Services
News Reporting and Journalism

Why Attend

The Global AMR Summit is the only event of its kind to deliver leading market intelligence and industry presentations on disrupting extra cytoplasmic protein folding, anti-quorum sensing, antimicrobial photodynamic therapy, bacteriophage therapy, antimicrobial peptides, AI-based artificial antimicrobials, and various surveillance programs.

Subscribe for updates:

The Premier Forum for Anti-Microbials and Antimicrobial Resistance

Welcome to the Global AMR Summit 2023, where global biotechnology and pharmaceutical companies will meet with leading experts and researchers in Boston, Massachusetts, to discuss the causes and response to antibiotic resistance and to understand the value of novel antibiotics to address the threat of AMR to public health.

Anti-Microbial Resistance (AMR) is a serious and growing concern to global public health, with 1.5 million deaths annually. Due to the escalation of Antibiotic Resistance Pathogenic Bacteria (ARPB) and Multi-Drug Resistance (MDR) in pathogenic bacteria, public health is returning to the “pre-antibiotic era” because of the non-effectiveness of present antibiotics against bacterial infections. The lack of rapid diagnostic and poor infection prevention control has transformed AMR into a global public health threat.

Next-generation antimicrobials and vaccines to combat the ‘silent pandemic’ of antimicrobial resistance are on the priority list of global healthcare. Embracing new technologies, such as disrupting protein folding, photodynamic therapy, antimicrobial peptides, and AI-based antibiotics, will help overcome the challenges of Antimicrobial Resistance.

This year’s Global AMR Summit will become the world’s leading exhibition and conference exclusively for pharmaceutical and biotechnology companies to address scientific and business solutions in next-generation antimicrobials and vaccines to combat antimicrobial resistance.

Key topics on this year’s agenda include:

The future of drug development and vaccines to combat infections
New developments in protein folding to curb antimicrobial resistance
Latest research in antimicrobial photodynamic therapy as a molecular tool
The role of AI in the design and development of next-generation antimicrobials
Advances in antimicrobial peptides and the development of novel antibiotics
Global surveillance programs and stewardship platforms to control AMR

This event will provide a forum for global pharmaceutical and biotechnology stakeholders to network and build cross-market relationships to explore new technologies and technical know-how to address the challenges in antimicrobial and antimicrobial resistance.

Call for Presentation

If you would like to be a speaker at this event, please get in touch with sean.collins@iQ-Hub.com, subject heading “Call for Papers – Global AMR Summit 2023”

Book now
To secure your place at the Global AMR Summit 2023 or if you require more information, please get in touch with delegates@iQ-Hub.com.

Key topics for 2023:

The future of drug development and vaccines to combat infections
Understanding the mechanisms and drivers of antimicrobial resistance and fighting antimicrobial resistance through novel antimicrobials and vaccines.
New developments in protein folding to curb antimicrobial resistance
Explore more about the omics of antimicrobial resistance and disrupting extra cytoplasmic protein folding as molecular tools to fight antimicrobial resistance.
Latest research in antimicrobial photodynamic therapy as a molecular tool
Assessing the advances in photodynamic antimicrobial chemotherapy by conjugating biomaterials with photosensitizers as a molecular tool for antimicrobial resistance.
The role of AI in the design and development of next-generation antimicrobials
Looking at the role of artificial intelligence in advancing the design and discovery of novel artificial antimicrobials.
Advances in antimicrobial peptides and the development of novel antibiotics
Achieve a deeper understanding of drug repurposing in the development developing of novel antimicrobials, antimicrobial peptides, and quorum-sensing inhibitors as future strategies in antibacterial agent design.
Global surveillance programs and stewardship platforms to control AMR
Learn how surveillance programs and stewardship platforms can drive change in AMR and the importance of collaboration with politicians and policymakers to control AMR.

Testimonials

Provided a great learning opportunity and served as a very good networking event.
Mike Zimmer (Novartis)
I loved the show! Very informative conference and a great group of people.
Wensheng Du (GlaxoSmithKline)
Excellent conference. Very useful information. Well organized event and agenda was very appropriate.
Barry Rosen (Sanofi)
Highly informational event with lots of opportunities to engage with other people from the field.
Ying Wang (Johnson & Johnson)
Excellent speakers line up. Showcasing the science and results from across the industry.
Anne Renton (Merck)
Well organized and great discussions. Networking opportunities were excellent.
Carolyn Dulney (Roche)